Clincosm LogoSign in Get a demo

acute myelogenous leukemia

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • FT-2102 (olutasidenib)
    • +2 more
    • Los Angeles, California
    • +59 more
    Mar 2, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)

    Completed
    • Acute Myeloid Leukemia
    • +3 more
    • Los Angeles, California
    • +7 more
    Jun 25, 2019

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Acute Myelogenous Leukemia
    • Tucson, Arizona
    • +29 more
    Jun 17, 2019

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (BVD-523)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Los Angeles, California
    • +4 more
    Jan 9, 2019

    Acute Myelogenous Leukemia, MDS Trial in United States (Phase 1 - OXi4503, Phase 1 - OXi4503 + cytarabine, Phase 2 - OXi4503 +

    Unknown status
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndromes
    • Phase 1 - OXi4503
    • +2 more
    • Los Angeles, California
    • +3 more
    Jun 1, 2018

    Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)

    Completed
    • Myelodysplastic Syndrome
    • Acute Myelogenous Leukemia
    • Los Angeles, California
    • +7 more
    Jun 4, 2015

    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564

    Completed
    • Acute Myelogenous Leukemia
    • +3 more
    • BMS-936564 (Anti-CXCR4)
    • Birmingham, Alabama
    • +10 more
    Mar 5, 2015

    Acute Myelogenous Leukemia Trial in Los Angeles (Arsenic Trioxide (ATO), Ascorbic Acid)

    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • Arsenic Trioxide (ATO)
    • Ascorbic Acid
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center and Hospital
    Jul 16, 2014

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • Acute Myeloid Leukemia
    • Phoenix, Arizona
    • +19 more
    Mar 17, 2014

    Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • clofarabine (IV formulation)
    • +2 more
    • Scottsdale, Arizona
    • +56 more
    Mar 17, 2014

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Birmingham, Alabama
    • +12 more
    Mar 17, 2014

    Acute Myelogenous Leukemia Trial in United States (clofarabine (IV formulation))

    Completed
    • Acute Myelogenous Leukemia
    • clofarabine (IV formulation)
    • Los Angeles, California
    • +11 more
    Mar 17, 2014

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (CT53518)

    Completed
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Los Angeles, California
    • +4 more
    Mar 23, 2009